期刊文献+

盐酸多巴胺与注射用托拉塞米配伍分析 被引量:1

ANALYSIS THE COMBINED USE OF TORASEMIDE AND DOPAMINE
下载PDF
导出
摘要 目的对盐酸多巴胺与注射用托拉塞米配伍发生化学反应进行分析。方法在常温下(16℃),将盐酸多巴胺与注射用托拉塞米按不同剂量配伍,加入不同的溶剂中(0.9%氯化钠注射液或5%葡萄糖注射液),共分3组,第1组为同等剂量的多巴胺与托拉塞米加入不同剂量的5%葡萄糖注射液中,第2组为同等剂量的多巴胺与托拉塞米加入不同剂量的0.9%氯化钠注射液中,第3组为不同剂量的托拉塞米与同等剂量的盐酸多巴胺加入0.9%氯化钠注射液中,记录随时间变化各组液体颜色变化情况。结果第1组配伍试剂中5%葡萄糖注射液的剂量越大,出现颜色的改变的时间越迟,甚至未出现颜色改变,提示该颜色改变的化学反应与浓度相关;第2组配伍试剂中显示在0.9%氯化钠注射液中托拉塞米与盐酸多巴胺可能更容易出现化学反应;第3组配伍试剂中提示发生颜色变化的化学反应与托拉塞米的浓度相关。结论在治疗顽固性心衰时,虽然托拉塞米与盐酸多巴胺联合应用有较好的效果,但在应用时应注意二者存在配伍禁忌,应避免在同一静脉通道同时使用。 Objective To analyze the combined use of torasemide and dopamine. Method At normal temperature, to mix the dopamine injection with torasemide according to different doses, with different solvents (0.9% NaCl or 5% Glucose Injection). The experiment were divided into three groups. The first group was mixing the same dose of dopamine and torasemide into different doses of 5% glucose injection. The second groups was mixing the same dose dopamine and torasemide into different doses of 0.9% NaCl. The third group was admixing different doses of to- rasemide and the same dose dopamine with 0.9% NaCl. Recording the change of each liquid color with time. Result In the first group, as the dose of Glucose Injection increase, the emergence of color change time is late, and even does not appear the color change, with suggesting that the chemical reaction of the color change associated with concentration ; In the second group, the dopamine injection and torasemide may be more prone to chemical reaction in 0. 9% Sodium Chloride Injection; In the third group, it was proved that the color change of chemical reaction related with the concentration of torasemide. Conclusion In the treatment of intractable heart failure, although combining torasemide with dopamine always bring good result, but we should pay attention to the incompatibility. So we should avoid to use at the same time in the same vein channel.
出处 《现代医院》 2015年第12期98-100,共3页 Modern Hospitals
基金 江西省卫生计生委科研课题(编号:2014A174)
关键词 盐酸多巴胺 托拉塞米 配伍分析 Torasemide Dopamine Incompatibility
  • 相关文献

参考文献6

二级参考文献26

  • 1陈金梅.舒适护理干预对老年慢性心力衰竭患者心功能及生活质量的影响[J].现代医院,2012,12(S2):84-85. 被引量:9
  • 2蒋文,李一石,华潞,黄岩,刘晗,苏绮,王蓓,成小如,张阴凤.托拉塞米的利尿作用和安全性[J].中国临床药理学杂志,2004,20(6):416-419. 被引量:16
  • 3胡大一,吴彦.规范心力衰竭治疗 加强患者管理[J].中华心血管病杂志,2005,33(6):495-497. 被引量:124
  • 4Müller K,Gamba G,Jaquet F,et al.Torasemide vs.furosemidein primary care patients with chronic heart failure NTHAⅡtoⅣ:efficacy and quality of life[J].Eur J Heart Fail,2003,5(6):793-801. 被引量:1
  • 5Veeraveedu PT,Watanabe K,Ma M,et al.Torasemide,a long-acting loop diuretic,reduces the progression of myocarditis todilated cardiomyopathy[J].Eur J Pharmacol,2008,581(1-2):121-131. 被引量:1
  • 6Díez J,Coca A,de Teresa E,et al.TORAFIC study protocol:torasemide prolonged release versus furosemide in patientswith chronic heart failure[J].Expert Rev Cardiovasc Ther,2009,7(8):897-904. 被引量:1
  • 7Asare K.Management of loop diuretic resistance in the inten-sive care unit[J].Am J Health Syst Pharm,2009,66(18):1635-1640. 被引量:1
  • 8陈灏珠.实用内科学[M]第10版[M].北京:人民卫生出版社,1998.1475-1482. 被引量:93
  • 9Diez J, Coca A, de Teresa E, et al. TORAFIC study proto- col: torasemide prolonged release versus furosemide in pa- tients with chronic heart failure [ J ]. Expert Rev Cardiovasc Ther, 2009, 7(8): 897. 被引量:1
  • 10Veeraveedu P T, Watanabe K, Ma M, et al. Torasemide, a long- acting loop diuretic, reduces the progression of my- ocarditis to dilated cardiomyopathy [J ]. Eur J Pharmacol, 2008, 581(1-2).. 121. 被引量:1

共引文献36

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部